Ohio Man’s Lawsuit Alleges Invokana Responsible for Kidney Failure
Invokana Responsible For A Man's Kidney Failure. Janssen Pharmaceuticals and its parent company Johnson & Johnson are facing a product liability lawsuit that alleges the type 2 diabetes medication is responsible for an Ohio's man kidney failure. Combined with a proper diet and exercise program, Invokana (canaglifozin) is … [Read more...] about Ohio Man’s Lawsuit Alleges Invokana Responsible for Kidney Failure
Invokana Carries Risk of Lower Limb Amputation
Invokana May Increase Risk of Lower Limb Amputations. Regulators in the United Kingdom are warning that Invokana (canagliflozin), a type 2 diabetes medication manufactured by Johnson & Johnson subsidiary Janssen, may carry an increased risk of lower limb amputations. Similar warnings were recently issued by the European Medicines … [Read more...] about Invokana Carries Risk of Lower Limb Amputation
Actos Side Effects Lawsuits
Actos Colon Cancer Injury Lawsuits. Many respected studies have linked the Type 2 diabetes medication, Actos (pioglitazone HCI), to increased risks of developing bladder cancer. The Actos lawyers at Parker Waichman LLP are investigating a growing range of Actos side effects in addition to increased bladder cancer risks, … [Read more...] about Actos Side Effects Lawsuits
Tradjenta Lawsuits
Tradjenta Risk of Pancreatic Cancer. Tradjenta (linagliptin) is a type 2 diabetes medication developed by Eli Lilly and Boehringer Ingelheim; it belongs to a class of diabetes drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. Tradjenta was approved by the U.S. Food and Drug Administration (FDA) in May 2011. It is … [Read more...] about Tradjenta Lawsuits
More than $2M Actos Bladder Cancer Case Award
Actos Bladder Cancer Case. A jury in a Pennsylvania state court awarded more than $2 million to a woman who claimed Takeda Pharmaceuticals’ diabetes medication Actos (pioglitazone) caused her bladder cancer. The plaintiff’s case alleged that Takeda officials failed to adequately warn Frances Wisniewski’s doctor about the … [Read more...] about More than $2M Actos Bladder Cancer Case Award
FDA on Avandia Restrictions
Health Officials Consider Avandia Restrictions. The knell appeared to sound for Avandia a few years ago when federal health officials decided to almost ban the drug outright because it had been linked to myriad health problems. Today, the U.S. Food and Drug Administration (FDA) is appearing to go back on those restrictions as the … [Read more...] about FDA on Avandia Restrictions
NY Man Alleges that Actos Caused Bladder Cancer
Diabetes Medication Actos Caused Bladder Cancer. Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit on behalf of a man who developed bladder cancer after taking Actos. The lawsuit alleges that Actos caused the cancer and claims that the … [Read more...] about NY Man Alleges that Actos Caused Bladder Cancer
Avandia Blasted as GlaxoSmithKline Takes Another Blow to the Chin
Avandia May Cause Complications. Avandia has come under fire again after a German study found that the controversial diabetes medication did little to improve quality of life for patients using it. In fact, the analysis found that Avandia could actually worsen complications of the disease. The new study was conducted at … [Read more...] about Avandia Blasted as GlaxoSmithKline Takes Another Blow to the Chin
